Links

Last minute


Medtronic receives approval for new Resolute Integrity indications
Zenopa
The device has now been ratified for use in the treatment of acute coronary syndromes, acute myocardial infarction, unstable angina, bifurcations, total occlusions and in-stent restenosis, in addition to its existing indications for diabetes and ...


Ark Readies Phase 2 Study
Drug Discovery & Development
Ark Therapeutics Group plc has completed the dose ranging Phase 1 section of the academic study of Ark's VEGF-D adenoviral vector treatment for refractory angina. The study is being carried out in collaboration with the AIV Institute in Finland.
Ark Therapeutics Group plc Interim Management StatementPharmaLive.com (press release)

all 3 news articles »

Cardium (CXM) Reports New Gene Delivery Methods at Industry Conference
BiotechStockTrader.com
Generx (Ad5FGF-4) is a disease-modifying regenerative medicine biologic that is being developed to offer a one-time, non-surgical option for the treatment of myocardial ischemia in patients with stable angina due to coronary artery disease, ...

and more »
 

Hot stuff

angina



Bookmark us
  • Bookmark this page on del.icio.us
  • Bookmark this page on StumbleUpon
  • Bookmark this page on Digg
  • Bookmark this page on blogmarks
  • Bookmark this page on Ma.gnolia
  • Bookmark this page on Netvouz
  • Bookmark this page on Technorati
  • Bookmark this page on Wykop